Jon and Pete dig into suspicious spec buying of Intra-Cellular Therapies prior to Johnson & Johnson's acquisition announcement, Sage Therapeutics fielding a buyout offer, Moderna slumping on reduced COVID vaccine demand, and Abercrombie failing to impress investors.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.